Milovan Stankov-Pugès
CEO, NG Biotech
CEO and founder of NG Biotech, a company that develops, manufactures, and markets innovative rapid AMR diagnostic solutions in over 70 countries. Leading products such as NG-Test CARBA5 which detects and characterizes carbapenemases in 15 minutes have been developed through public/private collaborations combining deep AMR expertize to our technology. We strive to improve patient therapy outcomes through rapid test results which enable that the right treatment is given to the right patient at the right moment.